![168425-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2022-08/168425-Thumbnail%20Image.png?versionId=JjoyWheFwhkKCYx04Cr7i5H054ep7fq_&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T025910Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=2549c6493d707075b5cc44e5c598afd4e5e15352ac5f9a80a99463434a4057d6&itok=zbgXnSWl)
![163463-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2022-05/163463-thumbnail-image.png?versionId=BPwEyDfL8_MEECniodO5E37rXmyLieOj&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240617/us-west-2/s3/aws4_request&X-Amz-Date=20240617T113840Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=edc76b90965a38935fc4cd4208cc156717776bc687c9fbf86c0b8d1fcae6b41a&itok=Nkksbs9g)
Annually approximately 1.5 million Americans suffer from a traumatic brain injury (TBI) increasing the risk of developing a further neurological complication later in life [1-3]. The molecular drivers of the subsequent ensuing pathologies after the initial injury event are vast and include signaling processes that may contribute to neurodegenerative diseases such as Alzheimer’s Disease (AD). One such molecular signaling pathway that may link TBI to AD is necroptosis. Necroptosis is an atypical mode of cell death compared with traditional apoptosis, both of which have been demonstrated to be present post-TBI [4-6]. Necroptosis is initiated by tissue necrosis factor (TNF) signaling through the RIPK1/RIPK3/MLKL pathway, leading to cell failure and subsequent death. Prior studies in rodent TBI models report necroptotic activity acutely after injury, within 48 hours. Here, the study objective was to recapitulate prior data and characterize MLKL and RIPK1 cortical expression post-TBI with our lab’s controlled cortical impact mouse model. Using standard immunohistochemistry approaches, it was determined that the tissue sections acquired by prior lab members were of poor quality to conduct robust MLKL and RIPK1 immunostaining assessment. Therefore, the thesis focused on presenting the staining method completed. The discussion also expanded on expected results from these studies regarding the spatial distribution necroptotic signaling in this TBI model.
![168733-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2022-08/168733-Thumbnail%20Image.png?versionId=GXcVI1dl7vjO1.Wp0aJkf.Q8ArimS0yc&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T075619Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=2d6f5ac1d3b1862a337191bd6354e988602f2bdf5e5dec1d68f40a770c3e53c5&itok=USMbFzgr)
![189241-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2023-08/189241-Thumbnail%20Image.png?versionId=aB0Dt5Ys4t7Fm195B1wP4RmNgmrd5CjQ&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T030603Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=6391427f67747b15691c1b57dcaf70d6c72934a079f74f4cf956b34ba1cad6f2&itok=c9PIPBvB)
![187431-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2023-06/187431-Thumbnail%20Image.png?versionId=ulN2ryvKjziCjahRboCeV02ZOju5Br.T&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T065839Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=75fb937f7d8dc3fff68a8b2f0ccfb5826a82117e9b692b487130036a308345ee&itok=TGkBgbxi)
![187460-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2023-06/187460-Thumbnail%20Image.png?versionId=7fNqeZuAW3Lpj6CmDKxzGNtgETtHYl57&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T005736Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=3505b320e7ca51c7ced1e719db5fe04b5d6e2013cefb3122a8ddeda60c6e4e48&itok=sJqtvtZO)
Most protein-coding mRNAs in eukaryotes must undergo a series of processing steps so they can be exported from the nucleus and translated into protein. Cleavage and polyadenylation are vital steps in this maturation process. Improper cleavage and polyadenylation results in variation in the 3′ UTR length of genes, which is a hallmark of various human diseases. Previous data have shown that the majority of 3’UTRs of mRNAs from the nematode Caenorhabditis elegans terminate at an adenosine nucleotide, and that mutating this adenosine disrupts the cleavage reaction. It is unclear if the adenosine is included in the mature mRNA transcript or if it is cleaved off. To address this question, we are developing a novel method called the Terminal Adenosine Methylation (TAM) assay which will allow us to precisely define whether the cleavage reaction takes place upstream or downstream of this terminal adenosine. The TAM Assay utilizes the ability of the methyltransferase domain (MTD) of the human methyltransferase METTL16 to methylate the terminal adenosine of a test mRNA transcript prior to the cleavage reaction in vivo. The presence or absence of methylation at the terminal adenosine will then be identified using direct RNA sequencing. This project focuses on 1) preparing the chimeric construct that positions the MTD on the mRNA cleavage site of a test mRNA transcript, and 2) testing the functionality of this construct in vitro and developing a transgenic C. elegans strain expressing it. The TAM assay has the potential to be a valuable tool for elucidating the role of the terminal adenosine in cleavage and polyadenylation.
![193518-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2024-05/193518-Thumbnail%20Image.png?versionId=Uph4.l_AFmtSJrDjxIipgxw2v5ysHXKl&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T031836Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e19b16f370f6b4d58a59b8f7d031fb149dbaa8cde267c83fcd9522e4954a5012&itok=gpw4aBly)
![157621-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/157621-Thumbnail%20Image.png?versionId=wYgs4u0OYxQ2P_2sfYjKiskxhxSvKHGX&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240617/us-west-2/s3/aws4_request&X-Amz-Date=20240617T081635Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=accccbb82aad8ac22e49bd47c4998a3ecc8b27a419a3932f41f877f018c62ddd&itok=Ux4XgQAz)